RadioGlobal
Account…

Podcast · Inglés

Individualizing Target HbA1c Level

Projects In Knowledge, Inc

Hemoglobin A1 (HbA1c) measurement is widely used in the management of type 2 diabetes mellitus (T2DM). However, expert consensus and professional guidelines conflict as to the correct use of this tool for diagnosis and therapeutic decision-making. In this podcast, Zachary Bloomgarden, MD, argues that a "one-size-fits-all" approach to interpretation and use of HbA1c is inherently flawed. He discusses the reasons and strategies for individualizing treatment goals and HbA1c targets in patients with T2DM.

Episodes

Ordered by publication date.

Sep 30, 2010

Part 1. Has HbA1c Lowering Been Incorrectly Interpreted in Current Guidelines?

Sep 30, 2010

Part 2. Does HbA1c Provide a True Average Glucose Measurement with a High Degree of Accuracy in an Individual Patient?

Sep 30, 2010

Part 3. Should HbA1c Be Used in the Diagnosis of T2DM?

Sep 30, 2010

Part 4. Are There Methodologic Issues with Measuring HbA1c?

Sep 30, 2010

Part 5. Should Glycemic Goals Be the Same for All Patients?

More related podcasts

Other podcasts in Science & Medicine.

View category

Choose a station or episode

Your audio continues while you browse